報價延遲最少15分鐘:2025/01/21 05:28 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
113.48 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
3.29/5.29
|
|
企業價值
212.12B
|
| 資產負債 |
|
每股賬面淨值
22.94
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
40.11B
|
|
每股收益
23.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 05:28 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |